Balboa Wealth Partners’s Sotera Health SHC Stock Holding History

Balboa Wealth Partners’s Portfolio SHC Stock Details SHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-16,697	Closed	-$250K	–	314
2023 Q3	$250K	Buy	+16,697	New	+$282K	0.09%	184

Other funds holding SHC

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

MIG Capital Newport Beach, California $589M AUM 25.96% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Balboa Wealth Partners's SHC Position: Q4 2023 in Review

Balboa Wealth Partners sold out of Sotera Health (SHC) in Q4 2023, closing a stake of 16,697 shares — an estimated $250K sold.

Balboa Wealth Partners first reported a position in SHC in Q3 2023 and held it in 1 quarter. The position peaked at $250K in Q3 2023. 179 funds tracked by Wall St. Rank hold SHC as of Q4 2023.

Balboa Wealth Partners reported no remaining Sotera Health position as of Q4 2023 after selling out during the quarter.
Balboa Wealth Partners sold 16,697 Sotera Health shares in Q4 2023, an estimated $250K.
Balboa Wealth Partners first reported a position in Sotera Health in Q3 2023 and held it in 1 quarter.
Balboa Wealth Partners's Sotera Health position peaked at $250K in Q3 2023.
179 funds tracked by Wall St. Rank held Sotera Health as of Q4 2023.

Based on Balboa Wealth Partners's 13F filing for Q4 2023, filed 9 Feb 2024.